Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 24, 2026
Intuitive Machines (LUNR) vs Rocket Lab (RKLB): Backlog Momentum and Positioning in the Commercial Space Sector

Intuitive Machines (LUNR) vs Rocket Lab (RKLB): Backlog Momentum and Positioning in the Commercial Space Sector

Key Takeaways

  • LUNR reported Q2 2026 revenue of $206 million with a record $1.8 billion backlog driven by spacecraft and infrastructure contracts.
  • RKLB posted Q2 2026 revenue of $234 million, up 62% year over year, with backlog reaching $2.36 billion across launch and space systems.
  • Both companies operate in the aerospace and defense sector, with LUNR focused on lunar and communications infrastructure and RKLB emphasizing launch services and satellite manufacturing.
  • Recent market activity shows contract wins boosting sentiment for LUNR, while RKLB highlighted execution milestones amid broader valuation compression from prior highs.
  • Relative performance reflects sector volatility, with both stocks exhibiting sensitivity to contract announcements and earnings execution over recent weeks.
  • Market positioning differs by scale, with RKLB maintaining a significantly larger market capitalization and backlog compared to LUNR.

Setting the Context

Intuitive Machines (LUNR) and Rocket Lab USA (RKLB) represent distinct approaches within the commercial space industry. The comparison examines their business models, recent financial results, and market dynamics to assist investors and traders evaluating exposure to space infrastructure and launch capabilities. This analysis appeals to those monitoring aerospace and defense equities, particularly participants seeking insights into relative performance and positioning amid ongoing sector developments. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

LUNR Overview and Recent Performance

Intuitive Machines (LUNR) develops lunar landers, spacecraft platforms, and space communications infrastructure primarily for civil, commercial, and national security customers. In recent market activity, the company reported second-quarter revenue of $206 million alongside a record backlog of $1.8 billion, reflecting expanded awards in satellite production and NASA-related programs. Contract announcements, including a multi-satellite communications program valued above $600 million, contributed to sentiment shifts during recent weeks. Performance has been influenced by execution on existing backlog and diversification across customer segments, though quarterly results showed variance from some analyst expectations.

RKLB Overview and Recent Performance

Rocket Lab USA (RKLB) provides launch services via the Electron rocket and develops space systems, including satellites and components. Recent market activity featured second-quarter revenue of $234 million, representing 62% year-over-year growth, with backlog expanding to $2.36 billion. Progress on the Neutron medium-lift rocket and acquisitions supported operational updates. Stock behavior reflected broader sector movements and valuation adjustments from earlier peaks, tempered by consistent demand signals in launch and space systems segments over recent weeks. From what I see, the revenue growth trajectory here stands out.

Head-to-Head Comparison

Intuitive Machines (LUNR) centers on lunar delivery and communications infrastructure with a focus on milestone-driven contracts, while Rocket Lab USA (RKLB) integrates launch services with satellite manufacturing for broader orbital applications. Growth drivers for LUNR include NASA CLPS missions and national security awards, contrasting with RKLB’s emphasis on Electron flight cadence and Neutron development. Recent momentum for LUNR stems from backlog expansion and specific contract wins, whereas RKLB highlights revenue scale and acquisition integration. Risk factors encompass execution timelines and customer concentration for both, with RKLB carrying larger absolute scale and LUNR showing higher relative volatility in market capitalization terms. Sector exposure overlaps in aerospace and defense, though market sentiment has responded differently to their respective earnings releases and order flows in recent weeks. One thing that stands out is how contract flow influences each name differently.

AI-Assisted Assessment

Based on observable factors such as backlog consistency, revenue trajectory, and relative positioning within the sector, Tickeron’s AI would currently assign a probabilistic preference toward Rocket Lab USA (RKLB) due to its larger backlog scale and diversified revenue streams. Intuitive Machines (LUNR) demonstrates strong contract momentum that could support trend continuation if execution aligns. This assessment reflects data patterns rather than guarantees of future outcomes. I’m watching this closely as execution details unfold.

Using Tickeron’s AI Tools in Practice

In my view, incorporating data-driven resources can add clarity when evaluating names like these in a volatile sector. I turned to Tickeron’s AI Trading Bots to review automated strategy performance across aerospace equities and found the historical metrics useful for context. This approach helps frame the relative positioning without replacing fundamental analysis. The resource offers a range of bots with documented win rates and drawdown data suited to current conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: RKLB, LUNR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RKLB's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RKLB turned positive on September 15, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in 40 of 44 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Oscillator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on RKLB as a result. In 75 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

RKLB moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +11.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 261 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 50-day moving average for RKLB moved below the 200-day moving average on August 27, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

RKLB broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RKLB entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. RKLB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.870) is normal, around the industry mean (6.563). P/E Ratio (27.472) is within average values for comparable stocks, (59.608). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.576). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.155).

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.67B. The market cap for tickers in the group ranges from 4.49 to 2T. SPCX holds the highest valuation in this group at 2T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -0%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -2%. BETA experienced the highest price growth at 20%, while VWAV experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
RKLB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Intuitive Machines (LUNR) vs Rocket Lab (RKLB): Backlog Momentum and Positioning in the Commercial Space Sector